{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:36:12Z","timestamp":1794008172533,"version":"4.8.0"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.pneurobio.2022.102270","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T11:21:08Z","timestamp":1650280868000},"page":"102270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":314,"special_numbering":"C","title":["Amyloid \u03b2, Tau, and \u03b1-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases"],"prefix":"10.1016","volume":"214","author":[{"given":"Urmi","family":"Sengupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakez","family":"Kayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2022.102270_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/19336896.2016.1223003","article-title":"Tunneling nanotubes: a possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases","volume":"10","author":"Abounit","year":"2016","journal-title":"Prion"},{"key":"10.1016\/j.pneurobio.2022.102270_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molmed.2007.02.004","article-title":"Abeta, tau and ApoE4 in Alzheimer\u2019s disease: the axonal connection","volume":"13","author":"Adalbert","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.pneurobio.2022.102270_bib3","first-page":"41","article-title":"Advanced magnetic resonance imaging of neurodegenerative diseases","volume":"38","author":"Agosta","year":"2017","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib4","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/brain\/awz100","article-title":"Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody","volume":"142","author":"Albert","year":"2019","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3389\/fnins.2020.00893","article-title":"Microglial activation and inflammation as a factor in the pathogenesis of progressive supranuclear palsy (PSP)","volume":"14","author":"Alster","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41398-020-00954-8","article-title":"Neuroinflammation in dementia with Lewy bodies: a human post-mortem study","volume":"10","author":"Amin","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pneurobio.2022.102270_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s13311-016-0474-y","article-title":"Amyloid imaging: poised for integration into medical practice","volume":"14","author":"Anand","year":"2017","journal-title":"Neurother.: J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.pneurobio.2022.102270_bib8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nm.3885","article-title":"Inhibition of amyloid-beta plaque formation by alpha-synuclein","volume":"21","author":"Bachhuber","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2022.102270_bib9","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fncel.2018.00488","article-title":"Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13195-020-00710-6","article-title":"Effect of APOE epsilon4 genotype on amyloid-beta and tau accumulation in Alzheimer\u2019s disease","volume":"12","author":"Baek","year":"2020","journal-title":"Alzheimer\u2019s. Res. Ther."},{"key":"10.1016\/j.pneurobio.2022.102270_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-020-00596-4","article-title":"Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer\u2019s disease and PET amyloid-positive patient identification","volume":"12","author":"Barthelemy","year":"2020","journal-title":"Alzheimer\u2019s. Res. Ther."},{"key":"10.1016\/j.pneurobio.2022.102270_bib12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","article-title":"Amyloid-beta (abeta) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of lewy body disorders with abeta pathology","volume":"105","author":"Bassil","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2022.102270_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","article-title":"TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy","volume":"12","author":"Bemiller","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2022.102270_bib14","doi-asserted-by":"crossref","first-page":"19656","DOI":"10.1038\/s41598-020-72355-2","article-title":"Extracellular vesicles from amyloid-beta exposed cell cultures induce severe dysfunction in cortical neurons","volume":"10","author":"Beretta","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2022.102270_bib15","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1007\/s00259-020-04788-w","article-title":"Early-phase [(18)F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury","volume":"47","author":"Beyer","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.pneurobio.2022.102270_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41541-018-0046-8","article-title":"Prospects for strain-specific immunotherapy in Alzheimer\u2019s disease and tauopathies","volume":"3","author":"Bittar","year":"2018","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.pneurobio.2022.102270_bib17","doi-asserted-by":"crossref","first-page":"fcz004","DOI":"10.1093\/braincomms\/fcz004","article-title":"Neurotoxic tau oligomers after single versus repetitive mild traumatic brain injury","volume":"1","author":"Bittar","year":"2019","journal-title":"Brain Commun."},{"key":"10.1016\/j.pneurobio.2022.102270_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104707","article-title":"Advances and considerations in AD tau-targeted immunotherapy","volume":"134","author":"Bittar","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2022.102270_bib19","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00702-019-02062-4","article-title":"Salivary alpha-synuclein as a biomarker for Parkinson\u2019s disease: a systematic review","volume":"126","author":"Bougea","year":"2019","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pneurobio.2022.102270_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib21","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.1315346111","article-title":"Solution conditions determine the relative importance of nucleation and growth processes in alpha-synuclein aggregation","volume":"111","author":"Buell","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pneurobio.2022.102270_bib22","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-beta and tau in Alzheimer\u2019s disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nchembio.283","article-title":"A causative link between the structure of aberrant protein oligomers and their toxicity","volume":"6","author":"Campioni","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/acs.biochem.9b00655","article-title":"Interactions between Soluble Species of beta-Amyloid and alpha-Synuclein Promote Oligomerization while Inhibiting Fibrillization","volume":"59","author":"Candreva","year":"2020","journal-title":"Biochemistry"},{"issue":"Suppl 1","key":"10.1016\/j.pneurobio.2022.102270_bib25","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.3233\/JAD-132477","article-title":"Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds","volume":"40","author":"Castillo-Carranza","year":"2014","journal-title":"J. Alzheimer\u2019s. Dis. JAD"},{"key":"10.1016\/j.pneurobio.2022.102270_bib26","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1523\/JNEUROSCI.4989-14.2015","article-title":"Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer\u2019s disease mouse model","volume":"35","author":"Castillo-Carranza","year":"2015","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.biopsych.2017.12.018","article-title":"alpha-Synuclein Oligomers Induce a Unique Toxic Tau Strain","volume":"84","author":"Castillo-Carranza","year":"2018","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pneurobio.2022.102270_bib28","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fneur.2019.01388","article-title":"Plasma and serum alpha-synuclein as a biomarker of diagnosis in patients with Parkinson\u2019s disease","volume":"10","author":"Chang","year":"2019","journal-title":"Front Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.pneurobio.2022.102270_bib30","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib31","doi-asserted-by":"crossref","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The amyloid-beta oligomer hypothesis: beginning of the third decade","volume":"64","author":"Cline","year":"2018","journal-title":"J. Alzheimer\u2019S. Dis. JAD"},{"key":"10.1016\/j.pneurobio.2022.102270_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00401-019-02087-9","article-title":"From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy","volume":"139","author":"Colin","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jns.2017.09.039","article-title":"CSF biomarkers beta-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes","volume":"382","author":"Constantinides","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1212\/CON.0000000000000819","article-title":"Synucleinopathies","volume":"26","author":"Coon","year":"2020","journal-title":"Continuum"},{"key":"10.1016\/j.pneurobio.2022.102270_bib35","article-title":"Alzheimer\u2019s disease drug development pipeline: 2020","volume":"6","author":"Cummings","year":"2020","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.pneurobio.2022.102270_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jocn.2020.04.088","article-title":"Clinicopathological overlap of neurodegenerative diseases: a comprehensive review","volume":"78","author":"Das","year":"2020","journal-title":"J. Clin. Neurosci.: Off. J. Neurosurg. Soc. Australas."},{"key":"10.1016\/j.pneurobio.2022.102270_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay3069","article-title":"APOE genotype regulates pathology and disease progression in synucleinopathy","volume":"12","author":"Davis","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pneurobio.2022.102270_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2022.102270_bib39","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/mds.27001","article-title":"Tau\/alpha-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study","volume":"32","author":"Delgado-Alvarado","year":"2017","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"key":"10.1016\/j.pneurobio.2022.102270_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00702-016-1650-2","article-title":"Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson\u2019s disease","volume":"124","author":"Ding","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pneurobio.2022.102270_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228645","article-title":"The role of alpha-synuclein oligomers in Parkinson\u2019s disease","volume":"21","author":"Du","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib42","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100760","article-title":"Ectosomes: a new mechanism for non-exosomal secretion of tau protein","volume":"9","author":"Dujardin","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.pneurobio.2022.102270_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0938-9","article-title":"Tau molecular diversity contributes to clinical heterogeneity in Alzheimer\u2019s disease","author":"Dujardin","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2022.102270_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/alzrt74","article-title":"Mitochondrial dysfunction - the beginning of the end in Alzheimer\u2019s disease? Separate and synergistic modes of tau and amyloid-beta toxicity","volume":"3","author":"Eckert","year":"2011","journal-title":"Alzheimer\u2019s. Res. Ther."},{"key":"10.1016\/j.pneurobio.2022.102270_bib46","doi-asserted-by":"crossref","first-page":"19393","DOI":"10.1038\/srep19393","article-title":"Extracellular Tau oligomers produce an immediate impairment of LTP and memory","volume":"6","author":"Fa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2022.102270_bib47","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/jnc.14809","article-title":"Parkinson\u2019s disease biomarkers based on alpha-synuclein","volume":"150","author":"Fayyad","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2022.102270_bib48","article-title":"Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: implications for Parkinson\u2019s disease","author":"Feng","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13080","article-title":"Measuring biological aging in humans: A quest","volume":"19","author":"Ferrucci","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.pneurobio.2022.102270_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fncel.2018.00329","article-title":"Role of Microglia TLRs in Neurodegeneration","volume":"12","author":"Fiebich","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"546","key":"10.1016\/j.pneurobio.2022.102270_bib51","first-page":"e549","article-title":"TREM2 analysis and increased risk of Alzheimer\u2019s disease","volume":"36","author":"Finelli","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pneurobio.2022.102270_bib52","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","article-title":"Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of alzheimer disease neuropathologic changes","volume":"77","author":"Fleisher","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib53","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1096\/fj.10-179192","article-title":"Phosphorylated alpha-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson\u2019s disease","volume":"25","author":"Foulds","year":"2011","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109419","article-title":"Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer\u2019s disease and frontotemporal dementia","volume":"36","author":"Gaikwad","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.pneurobio.2022.102270_bib55","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1021\/cn500143n","article-title":"Advances in therapeutics for neurodegenerative tauopathies: moving toward the specific targeting of the most toxic tau species","volume":"5","author":"Gerson","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/2051-5960-2-73","article-title":"Characterization of tau oligomeric seeds in progressive supranuclear palsy","volume":"2","author":"Gerson","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.pneurobio.2022.102270_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-018-0245-9","article-title":"Tau oligomers mediate alpha-synuclein toxicity and can be targeted by immunotherapy.","volume":"13","author":"Gerson","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2022.102270_bib58","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein","volume":"300","author":"Giasson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pneurobio.2022.102270_bib59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1515\/REVNEURO.2010.21.2.83","article-title":"The monomer state of beta-amyloid: where the Alzheimer\u2019s disease protein meets physiology","volume":"21","author":"Giuffrida","year":"2010","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib60","first-page":"S53","article-title":"The synucleinopathies: twenty years on","volume":"7","author":"Goedert","year":"2017","journal-title":"J. Park\u2019s. Dis."},{"key":"10.1016\/j.pneurobio.2022.102270_bib61","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1093\/brain\/awz278","article-title":"Elevated tau PET signal depends on abnormal amyloid levels and is uncommon in unimpaired individuals","volume":"142","author":"Gordon","year":"2019","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib62","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","article-title":"Molecular pathogenesis of the tauopathies","volume":"14","author":"Gotz","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib63","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1172\/JCI138179","article-title":"Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration","volume":"130","author":"Gratuze","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.pneurobio.2022.102270_bib64","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210542","article-title":"Activated microglia mitigate Abeta-associated tau seeding and spreading","volume":"218","author":"Gratuze","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pneurobio.2022.102270_bib65","doi-asserted-by":"crossref","first-page":"962","DOI":"10.15252\/embr.201643519","article-title":"Posttranslational modification impact on the mechanism by which amyloid-beta induces synaptic dysfunction","volume":"18","author":"Grochowska","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.pneurobio.2022.102270_bib66","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.nbd.2009.09.004","article-title":"Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice","volume":"37","author":"Grueninger","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2022.102270_bib67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2022.102270_bib68","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/brain\/awaa090","article-title":"Microglial exosomes facilitate alpha-synuclein transmission in Parkinson\u2019s disease","volume":"143","author":"Guo","year":"2020","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib69","first-page":"12164","article-title":"TREM2 deficiency aggravates alpha-synuclein-induced neurodegeneration and neuroinflammation in Parkinson\u2019s disease models","volume":"33","author":"Guo","year":"2019","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib70","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","article-title":"Neuroinflammation as a common feature of neurodegenerative disorders","volume":"10","author":"Guzman-Martinez","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib71","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1073\/pnas.1102664108","article-title":"Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein\/amyloid beta-peptides in human cerebrospinal fluid","volume":"108","author":"Halim","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pneurobio.2022.102270_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/alzrt255","article-title":"Levels of cerebrospinal fluid alpha-synuclein oligomers are increased in Parkinson\u2019s disease with dementia and dementia with Lewy bodies compared to Alzheimer\u2019s disease","volume":"6","author":"Hansson","year":"2014","journal-title":"Alzheimer\u2019s. Res. Ther."},{"key":"10.1016\/j.pneurobio.2022.102270_bib73","article-title":"Hyperactivity induced by soluble amyloid-beta oligomers in the early stages of Alzheimer\u2019s disease","volume":"13","author":"Hector","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib74","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2022.102270_bib75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-020-00368-6","article-title":"Initiation and propagation of alpha-synuclein aggregation in the nervous system","volume":"15","author":"Hijaz","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2022.102270_bib76","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5497046","article-title":"Proteostasis failure in neurodegenerative diseases: focus on oxidative stress","volume":"2020","author":"Hohn","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.pneurobio.2022.102270_bib77","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbrc.2021.03.091","article-title":"Tau induces formation of alpha-synuclein filaments with distinct molecular conformations","volume":"554","author":"Hojjatian","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pneurobio.2022.102270_bib78","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s42003-020-0792-9","article-title":"Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death","volume":"3","author":"Hughes","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib80","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-018-1907-y","article-title":"Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson\u2019s disease pathogenesis","volume":"137","author":"Hughes","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib81","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.nicl.2017.09.016","article-title":"Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer\u2019s disease","volume":"17","author":"Iaccarino","year":"2018","journal-title":"NeuroImage. Clin."},{"key":"10.1016\/j.pneurobio.2022.102270_bib82","doi-asserted-by":"crossref","first-page":"10855","DOI":"10.1021\/acsnano.8b03575","article-title":"Quantifying co-oligomer formation by alpha-synuclein","volume":"12","author":"Iljina","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.pneurobio.2022.102270_bib83","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3389\/fnins.2016.00408","article-title":"Alpha-synuclein oligomers-neurotoxic molecules in Parkinson\u2019s disease and other lewy body disorders","volume":"10","author":"Ingelsson","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib84","article-title":"The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in lewy body disorders","volume":"8","author":"Irwin","year":"2018","journal-title":"J. Alzheimer\u2019S. Dis. Park."},{"key":"10.1016\/j.pneurobio.2022.102270_bib85","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2022.102270_bib86","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12974-020-01820-6","article-title":"The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer\u2019s disease: a longitudinal PET study","volume":"17","author":"Ismail","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.pneurobio.2022.102270_bib87","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","article-title":"Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer\u2019s disease","volume":"11","author":"Janelidze","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pneurobio.2022.102270_bib88","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1100\/2011\/371893","article-title":"Interaction between alpha-synuclein and other proteins in neurodegenerative disorders","volume":"11","author":"Jellinger","year":"2011","journal-title":"TheScientificWorldJournal"},{"key":"10.1016\/j.pneurobio.2022.102270_bib89","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pneurobio.2022.102270_bib90","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0076-6879(06)13017-7","article-title":"Conformation-dependent anti-amyloid oligomer antibodies","volume":"413","author":"Kayed","year":"2006","journal-title":"Methods Enzymol."},{"issue":"Suppl 1","key":"10.1016\/j.pneurobio.2022.102270_bib91","first-page":"S67","article-title":"Molecular mechanisms of amyloid oligomers toxicity","volume":"33","author":"Kayed","year":"2013","journal-title":"J. Alzheimer\u2019S. Dis.: JAD"},{"key":"10.1016\/j.pneurobio.2022.102270_bib92","first-page":"791","article-title":"Soluble endogenous oligomeric alpha-synuclein species in neurodegenerative diseases: expression, spreading, and cross-talk","volume":"10","author":"Kayed","year":"2020","journal-title":"J. Park\u2019s Dis."},{"key":"10.1016\/j.pneurobio.2022.102270_bib93","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-018-1886-z","article-title":"Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons","volume":"136","author":"Khan","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib94","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer's disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2022.102270_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064649","article-title":"Altered serum IgG levels to alpha-synuclein in dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"8","author":"Koehler","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.pneurobio.2022.102270_bib96","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-170048","article-title":"Tau oligomers in sera of patients with Alzheimer\u2019s disease and aged controls","volume":"58","author":"Kolarova","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis. JAD"},{"key":"10.1016\/j.pneurobio.2022.102270_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030580","article-title":"Amyloid-beta peptides trigger aggregation of alpha-synuclein in vitro","volume":"25","author":"Koppen","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.pneurobio.2022.102270_bib98","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3233\/JAD-130458","article-title":"alpha-Synuclein in cerebrospinal fluid of Alzheimer\u2019s disease and mild cognitive impairment","volume":"36","author":"Korff","year":"2013","journal-title":"J. Alzheimer\u2019S. Dis.: JAD"},{"key":"10.1016\/j.pneurobio.2022.102270_bib99","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1039\/C3CS60431D","article-title":"Differences between amyloid-beta aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer\u2019s disease","volume":"43","author":"Kotler","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.pneurobio.2022.102270_bib100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12208","article-title":"Invited review: neuropathology of tauopathies: principles and practice","volume":"41","author":"Kovacs","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib101","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/WCO.0000000000000664","article-title":"Are comorbidities compatible with a molecular pathological classification of neurodegenerative diseases?","volume":"32","author":"Kovacs","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib102","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/jclinpath-2019-205952","article-title":"Molecular pathology of neurodegenerative diseases: principles and practice","volume":"72","author":"Kovacs","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib103","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1474-4422(20)30346-X","article-title":"PET imaging of neuroinflammation in neurological disorders","volume":"19","author":"Kreisl","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib104","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","article-title":"Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer\u2019s disease and other tauopathies","volume":"46","author":"Kroth","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.pneurobio.2022.102270_bib105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/alzrt258","article-title":"Truncated and modified amyloid-beta species","volume":"6","author":"Kummer","year":"2014","journal-title":"Alzheimer\u2019S. Res. Ther."},{"key":"10.1016\/j.pneurobio.2022.102270_bib106","first-page":"935","article-title":"Immunotherapies for aging-related neurodegenerative diseases-emerging perspectives and new targets","volume":"17","author":"Kwon","year":"2020","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.pneurobio.2022.102270_bib107","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/nan.12644","article-title":"Peripheral inflammation exacerbates alpha-synuclein toxicity and neuropathology in Parkinson\u2019s models","volume":"47","author":"La Vitola","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep00700","article-title":"Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau","volume":"2","author":"Lasagna-Reeves","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2022.102270_bib109","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1021\/bi1016233","article-title":"Preparation and characterization of neurotoxic tau oligomers","volume":"49","author":"Lasagna-Reeves","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.pneurobio.2022.102270_bib110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2022.102270_bib111","doi-asserted-by":"crossref","first-page":"22122","DOI":"10.1074\/jbc.M111.236257","article-title":"Amyloid-beta annular protofibrils evade fibrillar fate in Alzheimer disease brain","volume":"286","author":"Lasagna-Reeves","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2022.102270_bib112","doi-asserted-by":"crossref","DOI":"10.1096\/fj.11-199851","article-title":"Identification of oligomers at early stages of tau aggregation in Alzheimer\u2019s disease","author":"Lasagna-Reeves","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.pneurobio.2022.102270_bib113","first-page":"1946","article-title":"Identification of oligomers at early stages of tau aggregation in Alzheimer\u2019s disease","volume":"26","author":"Lasagna-Reeves","year":"2012","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib114","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41593-019-0541-x","article-title":"alpha-Synuclein strains target distinct brain regions and cell types","volume":"23","author":"Lau","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"Diagnosis of Alzheimer\u2019s disease utilizing amyloid and tau as fluid biomarkers","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.pneurobio.2022.102270_bib116","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.neuron.2021.02.010","article-title":"Trem2 restrains the enhancement of tau accumulation and neurodegeneration by beta-amyloid pathology","volume":"109","author":"Lee","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2022.102270_bib117","doi-asserted-by":"crossref","first-page":"11524","DOI":"10.1073\/pnas.1710311114","article-title":"TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy","volume":"114","author":"Leyns","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pneurobio.2022.102270_bib118","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","article-title":"TREM2 function impedes tau seeding in neuritic plaques","volume":"22","author":"Leyns","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.795036","article-title":"Targeting TREM2 for Parkinson\u2019s disease: where to go?","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11910-019-0918-y","article-title":"CSF biomarkers for early diagnosis of synucleinopathies: focus on idiopathic RBD","volume":"19","author":"Liguori","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.pneurobio.2022.102270_bib121","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mcn.2017.04.009","article-title":"Extensive uptake of alpha-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage","volume":"82","author":"Lindstrom","year":"2017","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib122","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/jnc.14945","article-title":"Soluble Abeta oligomers and protofibrils induce NLRP3 inflammasome activation in microglia","volume":"155","author":"Luciunaite","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2022.102270_bib123","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/alzrt109","article-title":"Examining the mechanisms that link beta-amyloid and alpha-synuclein pathologies","volume":"4","author":"Marsh","year":"2012","journal-title":"Alzheimer\u2019S. Res. Ther."},{"key":"10.1016\/j.pneurobio.2022.102270_bib124","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40478-018-0578-1","article-title":"Membrane binding, internalization, and sorting of alpha-synuclein in the cell","volume":"6","author":"Masaracchia","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.pneurobio.2022.102270_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085443","article-title":"Effects of baseline CSF alpha-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer\u2019s disease","volume":"8","author":"Mattsson","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.pneurobio.2022.102270_bib126","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/alz.12291","article-title":"Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia","volume":"17","author":"McAleese","year":"2021","journal-title":"Alzheimer\u2019S. Dement.: J. Alzheimer\u2019S. Assoc."},{"key":"10.1016\/j.pneurobio.2022.102270_bib127","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1523\/JNEUROSCI.1871-19.2019","article-title":"Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the abeta42:abeta40 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer\u2019s Mouse Model","volume":"40","author":"Meilandt","year":"2020","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib128","article-title":"Tau PET imaging with (18)F-PI-2620 in aging and neurodegenerative diseases","author":"Mormino","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.pneurobio.2022.102270_bib129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1750-1326-9-43","article-title":"Alpha-synuclein and tau: teammates in neurodegeneration?","volume":"9","author":"Moussaud","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2022.102270_bib130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","article-title":"What is the evidence that tau pathology spreads through prion-like propagation?","volume":"5","author":"Mudher","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.pneurobio.2022.102270_bib131","first-page":"911","article-title":"Tau PET imaging with (18)F-PI-2620 in patients with alzheimer disease and healthy controls: a first-in-humans study","volume":"61","author":"Mueller","year":"2020","journal-title":"J. Nucl. Med. Off. Publ., Soc. Nucl. Med."},{"key":"10.1016\/j.pneurobio.2022.102270_bib132","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s11011-020-00591-6","article-title":"Recent advances in tau-directed immunotherapy against Alzheimer\u2019s disease: an overview of pre-clinical and clinical development","volume":"35","author":"Ng","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.pneurobio.2022.102270_bib133","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","article-title":"Amyloid oligomers: a joint experimental\/computational perspective on Alzheimer\u2019s disease, Parkinson\u2019s disease, type ii diabetes, and amyotrophic lateral sclerosis","volume":"121","author":"Nguyen","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.pneurobio.2022.102270_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10050326","article-title":"Role of body-fluid biomarkers in Alzheimer\u2019s disease diagnosis","volume":"10","author":"Nguyen","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.pneurobio.2022.102270_bib135","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3233\/JAD-160912","article-title":"Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases","volume":"55","author":"Nilson","year":"2017","journal-title":"J. Alzheimer\u2019S. Dis. JAD"},{"key":"10.1016\/j.pneurobio.2022.102270_bib136","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","article-title":"Tau aggregation and its interplay with amyloid-beta","volume":"129","author":"Nisbet","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib137","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/ene.14208","article-title":"A longitudinal study on alpha-synuclein in plasma neuronal exosomes as a biomarker for Parkinson\u2019s disease development and progression","volume":"27","author":"Niu","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib138","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib139","first-page":"21","article-title":"Protofibrils of amyloid-beta are important targets of a disease-modifying approach for Alzheimer\u2019s disease","author":"Ono","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib140","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1042\/BST20180466","article-title":"LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders?","volume":"47","author":"Outeiro","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.pneurobio.2022.102270_bib141","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41582-019-0222-0","article-title":"SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases","volume":"15","author":"Paterson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib142","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fnins.2018.00628","article-title":"HMGB1: a common biomarker and potential target for TBI, neuroinflammation, epilepsy, and cognitive dysfunction","volume":"12","author":"Paudel","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib143","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1038\/s41467-019-10217-w","article-title":"Abeta-induced vulnerability propagates via the brain's default mode network","volume":"10","author":"Pascoal","year":"2019","journal-title":"Nature communications"},{"key":"10.1016\/j.pneurobio.2022.102270_bib144","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25071659","article-title":"Oligomerization and conformational change turn monomeric beta-amyloid and tau proteins toxic: their role in Alzheimer\u2019s pathogenesis","volume":"25","author":"Penke","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.pneurobio.2022.102270_bib145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fneur.2020.00563","article-title":"Ablating tau reduces hyperexcitability and moderates electroencephalographic slowing in transgenic mice expressing A53T human alpha-synuclein","volume":"11","author":"Peters","year":"2020","journal-title":"Front Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib146","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.celrep.2019.11.044","article-title":"Amyloid beta and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer\u2019s disease","volume":"29","author":"Pickett","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.pneurobio.2022.102270_bib147","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12974-020-01915-0","article-title":"Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition","volume":"17","author":"Price","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.pneurobio.2022.102270_bib148","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-019-02048-2","article-title":"Impact of TREM2 risk variants on brain region-specific immune activation and plaque microenvironment in Alzheimer\u2019s disease patient brain samples","volume":"138","author":"Prokop","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib149","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41419-020-2503-3","article-title":"Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer\u2019s disease, progressive supranuclear palsy and dementia with Lewy bodies","volume":"11","author":"Puangmalai","year":"2020","journal-title":"Cell death Dis."},{"key":"10.1016\/j.pneurobio.2022.102270_bib150","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26991","article-title":"LTP and memory impairment caused by extracellular Abeta and Tau oligomers is APP-dependent","volume":"6","author":"Puzzo","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.pneurobio.2022.102270_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111438","article-title":"TREM2, microglia, and Alzheimer\u2019s disease","volume":"195","author":"Qin","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.pneurobio.2022.102270_bib152","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-8-19","article-title":"TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson\u2019s disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2022.102270_bib153","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1039\/C9TB01871A","article-title":"Fundamentals of cross-seeding of amyloid proteins: an introduction","volume":"7","author":"Ren","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.pneurobio.2022.102270_bib154","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","author":"Robinson","year":"2018","journal-title":"Brain J.\u00a0Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-981-32-9358-8_15","article-title":"Associations between APOE variants, tau and alpha-synuclein","volume":"1184","author":"Rodriguez-Vieitez","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib156","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1038\/s41598-020-63398-6","article-title":"Oligomeric amyloid-beta induces early and widespread changes to the proteome in human iPSC-derived neurons","volume":"10","author":"Sackmann","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2022.102270_bib157","article-title":"Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease","author":"Salloway","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108104","article-title":"Tau immunotherapies: lessons learned, current status and future considerations","volume":"175","author":"Sandusky-Beltran","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pneurobio.2022.102270_bib159","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","article-title":"Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies","volume":"78","author":"Sengupta","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2022.102270_bib160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","article-title":"The role of amyloid-beta oligomers in toxicity, propagation, and immunotherapy","volume":"6","author":"Sengupta","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pneurobio.2022.102270_bib161","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/acn3.382","article-title":"Tau oligomers in cerebrospinal fluid in Alzheimer\u2019s disease","volume":"4","author":"Sengupta","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib162","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-020-01913-6","article-title":"Polymorphic alpha-synuclein strains modified by dopamine and docosahexaenoic acid interact differentially with tau protein","author":"Sengupta","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib163","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2022.102270_bib164","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14802\/jmd.19057","article-title":"Immunotherapy targeting neurodegenerative proteinopathies: alpha-synucleinopathies and tauopathies","volume":"13","author":"Shin","year":"2020","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.pneurobio.2022.102270_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238948","article-title":"Tauopathies: deciphering disease mechanisms to develop effective therapies","volume":"21","author":"Silva","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib166","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2174\/1567205016666190903102822","article-title":"Role of TREM2 in Alzheimer\u2019s disease and its consequences on beta- amyloid, tau and neurofibrillary tangles","volume":"16","author":"Singh","year":"2019","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.pneurobio.2022.102270_bib167","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00401-019-02032-w","article-title":"Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of alpha-synucleinopathy","volume":"138","author":"Singh","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-019-01977-2","article-title":"alpha-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease","volume":"138","author":"Sorrentino","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib169","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pneurobio.2022.102270_bib170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40478-020-00969-8","article-title":"Phosphorylation and oligomerization of alpha-synuclein associated with GSK-3beta activation in the rTg4510 mouse model of tauopathy","volume":"8","author":"Takaichi","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.pneurobio.2022.102270_bib171","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s40478-016-0386-4","article-title":"Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies","volume":"4","author":"Tardivel","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.pneurobio.2022.102270_bib172","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","article-title":"Association of apolipoprotein E epsilon4 with medial temporal tau independent of amyloid-beta","volume":"77","author":"Therriault","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib173","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-019-0155-y","article-title":"Erythrocytic alpha-Synuclein as a potential biomarker for Parkinson\u2019s disease","volume":"8","author":"Tian","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.pneurobio.2022.102270_bib174","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1021\/acs.biochem.9b01087","article-title":"Direct interaction between the beta-amyloid core and tau facilitates cross-seeding: a novel target for therapeutic intervention","volume":"59","author":"Tripathi","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.pneurobio.2022.102270_bib175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003135","article-title":"Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"3","author":"Tsigelny","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.pneurobio.2022.102270_bib176","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.jnen.0000225908.90052.07","article-title":"Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy","volume":"65","author":"Uchikado","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib177","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neuron.2018.02.018","article-title":"TREM2 and amyloid beta: a love-hate relationship","volume":"97","author":"Udeochu","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.pneurobio.2022.102270_bib178","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2 - a key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.pneurobio.2022.102270_bib179","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13311-015-0397-z","article-title":"Immunotherapeutic approaches targeting amyloid-beta, alpha-synuclein, and tau for the treatment of neurodegenerative disorders","volume":"13","author":"Valera","year":"2016","journal-title":"Neurother.: J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.pneurobio.2022.102270_bib180","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/mds.111","article-title":"alpha-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies","volume":"33","author":"van Steenoven","year":"2018","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.pneurobio.2022.102270_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.134919","article-title":"Targeting tau: clinical trials and novel therapeutic approaches","volume":"731","author":"VandeVrede","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pneurobio.2022.102270_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102212","article-title":"Interaction of APOE4 alleles and PET tau imaging in former contact sport athletes","volume":"26","author":"Vasilevskaya","year":"2020","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.pneurobio.2022.102270_bib183","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fnmol.2019.00107","article-title":"Spreading of alpha-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved","volume":"12","author":"Vasili","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105398","article-title":"THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency","volume":"155","author":"Vautheny","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pneurobio.2022.102270_bib185","doi-asserted-by":"crossref","first-page":"13713","DOI":"10.1038\/s41598-017-14175-5","article-title":"Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson\u2019s disease","volume":"7","author":"Vicente Miranda","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pneurobio.2022.102270_bib186","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-019-0172-x","article-title":"Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities","volume":"8","author":"Visanji","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.pneurobio.2022.102270_bib187","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","article-title":"Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease","volume":"11","author":"Vogel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pneurobio.2022.102270_bib188","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.pneurobio.2022.102270_bib189","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-016-0143-y","article-title":"The release and trans-synaptic transmission of Tau via exosomes","volume":"12","author":"Wang","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2022.102270_bib190","article-title":"Active immunotherapy and alternative therapeutic modalities for Alzheimer\u2019s disease","volume":"6","author":"Weninger","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.pneurobio.2022.102270_bib191","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jnc.13365","article-title":"Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses","volume":"136","author":"Wilkaniec","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2022.102270_bib192","doi-asserted-by":"crossref","first-page":"fcaa090","DOI":"10.1093\/braincomms\/fcaa090","article-title":"Differential cross-seeding properties of tau and alpha-synuclein in mouse models of tauopathy and synucleinopathy","volume":"2","author":"Williams","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.pneurobio.2022.102270_bib193","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1074\/jbc.M112.394528","article-title":"Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons","volume":"288","author":"Wu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2022.102270_bib194","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","article-title":"Neuronal activity enhances tau propagation and tau pathology in vivo","volume":"19","author":"Wu","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2022.102270_bib195","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature20411","article-title":"Ageing, neurodegeneration and brain rejuvenation","volume":"539","author":"Wyss-Coray","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2022.102270_bib196","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","article-title":"APOE epsilon2 is associated with increased tau pathology in primary tauopathy","author":"Zhao","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008222000569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008222000569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:12:14Z","timestamp":1759551134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008222000569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":196,"alternative-id":["S0301008222000569"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2022.102270","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloid \u03b2, Tau, and \u03b1-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2022.102270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102270"}}